Dr. George S. Howard
Overview
George Howard is an Oncologist in Sterling Heights, Michigan. Dr. Howard has been practicing medicine for over 24 years and is rated as an Experienced provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Adult Immune Thrombocytopenia, Familial Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Gastrostomy. Dr. Howard is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
44344 Dequindre Road, Suite 260, Sterling Heights, MI 48314
53960 Van Dyke Avenue, Shelby Township, MI 48316
Additional Areas of Focus
Dr. Howard has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Mitchell Folbe MD PC
Mitchell Folbe is an Oncologist in Sterling Heights, Michigan. Dr. Folbe has been practicing medicine for over 34 years and is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). His top areas of expertise are Angiosarcoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Folbe is currently accepting new patients.
Promedica Multi Specialty Physicians
Chang Xia is a Hematologist Oncology specialist and a Hematologist in Monroe, Michigan. Dr. Xia is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). Her top areas of expertise are Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Xia is currently accepting new patients.
Mclaren Oakland
Rana Bilbeisi is a Hematologist Oncology specialist and a Hematologist in Mount Clemens, Michigan. Dr. Bilbeisi is rated as a Distinguished provider by MediFind in the treatment of Atypical Hemolytic Uremic Syndrome (aHUS). Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Chronic Lymphocytic Leukemia (CLL), and Paget Disease of the Breast. Dr. Bilbeisi is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Immune ThrombocytopeniaDr. Howard isDistinguished. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Howard isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Howard isDistinguished. Learn about Anal Cancer.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Howard isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Chromophobe Renal Cell CarcinomaDr. Howard isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Howard isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Howard isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Howard isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Adult Soft Tissue SarcomaDr. Howard isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Howard isAdvanced. Learn about Agranulocytosis.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acquired HemophiliaDr. Howard isExperienced. Learn about Acquired Hemophilia.
- Acute Lymphoblastic Leukemia (ALL)Dr. Howard isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Howard isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Howard isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adenoid Cystic CarcinomaDr. Howard isExperienced. Learn about Adenoid Cystic Carcinoma.